MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAF(V600E) Mutation Detected in Circulating-Free DNA

by Salemi, Rossella, Falzone, Luca, Madonna, Gabriele, Polesel, Jerry, Cinà, Diana, Mallardo, Domenico, Ascierto, Paolo A., Libra, Massimo, Candido, Saverio
Published in Front Pharmacol (2018)

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab

by Morello, Silvana, Capone, Mariaelena, Sorrentino, Claudia, Giannarelli, Diana, Madonna, Gabriele, Mallardo, Domenico, Grimaldi, Antonio M., Pinto, Aldo, Ascierto, Paolo Antonio
Published in J Transl Med (2017)

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

by Tallerico, Rossana, Cristiani, Costanza M, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Simeone, Ester, Dominijanni, Andrea, Grimaldi, Antonio M, Colucci, Francesco, Ascierto, Paolo A, Carbone, Ennio
Published in J Transl Med (2015)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

by Ascierto, Paolo A., Capone, Mariaelena, Grimaldi, Antonio M., Mallardo, Domenico, Simeone, Ester, Madonna, Gabriele, Roder, Heinrich, Meyer, Krista, Asmellash, Senait, Oliveira, Carlos, Roder, Joanna, Grigorieva, Julia
Published in J Immunother Cancer (2019)

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

by Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Madonna, Gabriele, Festino, Lucia, Grimaldi, Antonio Maria, Vanella, Vito, Simeone, Ester, Paone, Miriam, Palmieri, Giuseppe, Cavalcanti, Ernesta, Caracò, Corrado, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2018)

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Aut...

by Ruggiero, Ciro Francesco, Malpicci, Debora, Fattore, Luigi, Madonna, Gabriele, Vanella, Vito, Mallardo, Domenico, Liguoro, Domenico, Salvati, Valentina, Capone, Mariaelena, Bedogni, Barbara, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro
Published in Cancers (Basel) (2019)

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

by Madonna, Gabriele, Ballesteros-Merino, Carmen, Feng, Zipei, Bifulco, Carlo, Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Caracò, Corrado, Botti, Gerardo, Fox, Bernard A., Ascierto, Paolo A.
Published in Oncoimmunology (2018)

miR-579-3p controls melanoma progression and resistance to target therapy

by Fattore, Luigi, Mancini, Rita, Acunzo, Mario, Romano, Giulia, Laganà, Alessandro, Pisanu, Maria Elena, Malpicci, Debora, Madonna, Gabriele, Mallardo, Domenico, Capone, Marilena, Fulciniti, Franco, Mazzucchelli, Luca, Botti, Gerardo, Croce, Carlo M., Ascierto, Paolo Antonio, Ciliberto, Gennaro
Published in Proc Natl Acad Sci U S A (2016)

The Ratio of GrzB(+) − FoxP3(+) over CD3(+) T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma

by Scognamiglio, Giosuè, Capone, Mariaelena, Sabbatino, Francesco, Di Mauro, Annabella, Cantile, Monica, Cerrone, Margherita, Madonna, Gabriele, Grimaldi, Antonio Maria, Mallardo, Domenico, Palla, Marco, Sarno, Sabrina, Anniciello, Anna Maria, Di Bonito, Maurizio, Ascierto, Paolo Antonio, Botti, Gerardo
Published in Cancers (Basel) (2021)

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

by Fattore, Luigi, Ruggiero, Ciro Francesco, Pisanu, Maria Elena, Liguoro, Domenico, Cerri, Andrea, Costantini, Susan, Capone, Francesca, Acunzo, Mario, Romano, Giulia, Nigita, Giovanni, Mallardo, Domenico, Ragone, Concetta, Carriero, Maria Vincenza, Budillon, Alfredo, Botti, Gerardo, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro
Published in Cell Death Differ (2018)

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

by Simeone, Ester, Scognamiglio, Giosuè, Capone, Mariaelena, Giannarelli, Diana, Grimaldi, Antonio M., Mallardo, Domenico, Madonna, Gabriele, Curvietto, Marcello, Esposito, Assunta, Sandomenico, Fabio, Sabbatino, Francesco, Bayless, Nicholas L., Warren, Sarah, Ong, SuFey, Botti, Gerardo, Flaherty, Keith T., Ferrone, Soldano, Ascierto, Paolo A.
Published in J Transl Med (2021)

Peripheral CD8 effector memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

by Wistuba-Hamprecht, Kilian, Martens, Alexander, Heubach, Florian, Romano, Emanuela, Foppen, Marnix Geukes, Yuan, Jianda, Postow, Michael, Wong, Phillip, Mallardo, Domenico, Schilling, Bastian, Di Giacomo, Anna Maria, Khammari, Amir, Dreno, Brigitte, Maio, Michele, Schadendorf, Dirk, Ascierto, Paolo A., Wolchok, Jedd D., Blank, Christian U., Garbe, Claus, Pawelec, Graham, Weide, Benjamin
Published in Eur J Cancer (2017)

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

by Montesarchio, Vincenzo, Parrella, Roberto, Iommelli, Chiara, Bianco, Antonella, Manzillo, Elio, Fraganza, Fiorentino, Palumbo, Cristiana, Rea, Gaetano, Murino, Patrizia, De Rosa, Rosanna, Atripaldi, Luigi, D’Abbraccio, Maurizio, Curvietto, Marcello, Mallardo, Domenico, Celentano, Egidio, Grimaldi, Antonio Maria, Palla, Marco, Trojaniello, Claudia, Vitale, Maria Grazia, Million-Weaver, Samuel Lewis, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2020)

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

by Isgrò, Maria Antonietta, Vitale, Maria Grazia, Celentano, Egidio, Nocerino, Flavia, Porciello, Giuseppe, Curvietto, Marcello, Mallardo, Domenico, Montagnese, Concetta, Russo, Luigi, Zanaletti, Nicoletta, Avallone, Antonio, Pensabene, Matilde, De Laurentiis, Michelino, Centonze, Sara, Pignata, Sandro, Cannella, Lucia, Morabito, Alessandro, Caponigro, Francesco, Botti, Gerardo, Masucci, Giuseppe Valentino, Giannarelli, Diana, Cavalcanti, Ernesta, Ascierto, Paolo Antonio
Published in J Transl Med (2021)

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients

by Tallerico, Rossana, Cristiani, Costanza M., Staaf, Elina, Garofalo, Cinzia, Sottile, Rosa, Capone, Mariaelena, Pico de Coaña, Yago, Madonna, Gabriele, Palella, Eleonora, Wolodarski, Maria, Carannante, Valentina, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Johansson, Sofia, Frumento, Paolo, Gulletta, Elio, Anichini, Andrea, Colucci, Francesco, Ciliberto, Gennaro, Kiessling, Rolf, Kärre, Klas, Ascierto, Paolo A., Carbone, Ennio
Published in Oncoimmunology (2016)

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

by Turiello, Roberta, Capone, Mariaelena, Giannarelli, Diana, Morretta, Elva, Monti, Maria Chiara, Madonna, Gabriele, Mallardo, Domenico, Festino, Lucia, Azzaro, Rosa, Levesque, Mitchell P, Imhof, Laurence, Weide, Benjamin, Amaral, Teresa, Chevrier, Marc, Sucker, Antje, Rutkowski, Piotr, Schadendorf, Dirk, Lebbe, Celeste, Luke, Jason John, Wistuba-Hamprecht, Kilian, Dummer, Reinhard, Pinto, Aldo, Morello, Silvana, Ascierto, Paolo A
Published in J Immunother Cancer (2020)

Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer

by Coutzac, Clélia, Jouniaux, Jean-Mehdi, Paci, Angelo, Schmidt, Julien, Mallardo, Domenico, Seck, Atmane, Asvatourian, Vahe, Cassard, Lydie, Saulnier, Patrick, Lacroix, Ludovic, Woerther, Paul-Louis, Vozy, Aurore, Naigeon, Marie, Nebot-Bral, Laetitia, Desbois, Mélanie, Simeone, Ester, Mateus, Christine, Boselli, Lisa, Grivel, Jonathan, Soularue, Emilie, Lepage, Patricia, Carbonnel, Franck, Ascierto, Paolo Antonio, Robert, Caroline, Chaput, Nathalie
Published in Nat Commun (2020)

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

by Cortellini, Alessio, Vitale, Maria G., De Galitiis, Federica, Di Pietro, Francesca R., Berardi, Rossana, Torniai, Mariangela, De Tursi, Michele, Grassadonia, Antonino, Di Marino, Pietro, Santini, Daniele, Zeppola, Tea, Anesi, Cecilia, Gelibter, Alain, Occhipinti, Mario Alberto, Botticelli, Andrea, Marchetti, Paolo, Rastelli, Francesca, Pergolesi, Federica, Tudini, Marianna, Silva, Rosa Rita, Mallardo, Domenico, Vanella, Vito, Ficorella, Corrado, Porzio, Giampiero, Ascierto, Paolo A.
Published in J Transl Med (2019)

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

by Cortellini, Alessio, Tucci, Marco, Adamo, Vincenzo, Stucci, Luigia Stefania, Russo, Alessandro, Tanda, Enrica Teresa, Spagnolo, Francesco, Rastelli, Francesca, Bisonni, Renato, Santini, Daniele, Russano, Marco, Anesi, Cecilia, Giusti, Raffaele, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Gelibter, Alain, Occhipinti, Mario Alberto, Marconcini, Riccardo, Vitale, Maria Giuseppa, Nicolardi, Linda, Chiari, Rita, Bareggi, Claudia, Nigro, Olga, Tuzi, Alessandro, De Tursi, Michele, Petragnani, Nicola, Pala, Laura, Bracarda, Sergio, Macrini, Serena, Inno, Alessandro, Zoratto, Federica, Veltri, Enzo, Di Cocco, Barbara, Mallardo, Domenico, Vitale, Maria Grazia, Pinato, David James, Porzio, Giampiero, Ficorella, Corrado, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2020)

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

by Cortellini, Alessio, Buti, Sebastiano, Bersanelli, Melissa, Giusti, Raffaele, Perrone, Fabiana, Di Marino, Pietro, Tinari, Nicola, De Tursi, Michele, Grassadonia, Antonino, Cannita, Katia, Tessitore, Alessandra, Zoratto, Federica, Veltri, Enzo, Malorgio, Francesco, Russano, Marco, Anesi, Cecilia, Zeppola, Tea, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Cappellini, Gian Carlo Antonini, De Galitiis, Federica, Vitale, Maria Giuseppa, Rastelli, Francesca, Pergolesi, Federica, Berardi, Rossana, Rinaldi, Silvia, Tudini, Marianna, Silva, Rosa Rita, Pireddu, Annagrazia, Atzori, Francesco, Iacono, Daniela, Migliorino, Maria Rita, Gelibter, Alain, Occhipinti, Mario Alberto, Martella, Francesco, Inno, Alessandro, Gori, Stefania, Bracarda, Sergio, Zannori, Cristina, Mosillo, Claudia, Parisi, Alessandro, Porzio, Giampiero, Mallardo, Domenico, Fargnoli, Maria Concetta, Tiseo, Marcello, Santini, Daniele, Ascierto, Paolo A, Ficorella, Corrado
Published in Oncoimmunology (2020)